全文获取类型
收费全文 | 10546篇 |
免费 | 924篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 122篇 |
儿科学 | 414篇 |
妇产科学 | 218篇 |
基础医学 | 1486篇 |
口腔科学 | 222篇 |
临床医学 | 946篇 |
内科学 | 2293篇 |
皮肤病学 | 218篇 |
神经病学 | 994篇 |
特种医学 | 329篇 |
外科学 | 1773篇 |
综合类 | 102篇 |
一般理论 | 4篇 |
预防医学 | 742篇 |
眼科学 | 139篇 |
药学 | 631篇 |
中国医学 | 33篇 |
肿瘤学 | 836篇 |
出版年
2023年 | 60篇 |
2022年 | 53篇 |
2021年 | 230篇 |
2020年 | 161篇 |
2019年 | 288篇 |
2018年 | 339篇 |
2017年 | 259篇 |
2016年 | 242篇 |
2015年 | 278篇 |
2014年 | 389篇 |
2013年 | 475篇 |
2012年 | 632篇 |
2011年 | 655篇 |
2010年 | 447篇 |
2009年 | 368篇 |
2008年 | 477篇 |
2007年 | 540篇 |
2006年 | 505篇 |
2005年 | 465篇 |
2004年 | 413篇 |
2003年 | 370篇 |
2002年 | 354篇 |
2001年 | 321篇 |
2000年 | 320篇 |
1999年 | 317篇 |
1998年 | 126篇 |
1997年 | 109篇 |
1996年 | 111篇 |
1995年 | 110篇 |
1994年 | 101篇 |
1993年 | 74篇 |
1992年 | 199篇 |
1991年 | 200篇 |
1990年 | 172篇 |
1989年 | 171篇 |
1988年 | 130篇 |
1987年 | 150篇 |
1986年 | 131篇 |
1985年 | 94篇 |
1984年 | 73篇 |
1983年 | 52篇 |
1982年 | 33篇 |
1981年 | 46篇 |
1979年 | 59篇 |
1978年 | 46篇 |
1977年 | 42篇 |
1976年 | 37篇 |
1975年 | 31篇 |
1974年 | 36篇 |
1973年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
Wendy G. Anderson Stewart C. Alexander Keri L. Rodriguez Amy S. Jeffreys Maren K. Olsen Kathryn I. Pollak James A. Tulsky Robert M. Arnold 《Supportive care in cancer》2008,16(7):803-811
OBJECTIVE: Cancer patients have high levels of distress, yet oncologists often do not recognize patients' concerns. We sought to describe how patients with advanced cancer verbally express negative emotion to their oncologists. MATERIALS AND METHODS: As part of the Studying Communication in Oncologist-Patient Encounters Trial, we audio-recorded 415 visits that 281 patients with advanced cancer made to their oncologists at three US cancer centers. Using qualitative methodology, we coded for verbal expressions of negative emotion, identified words patients used to express emotion, and categorized emotions by type and content. RESULTS: Patients verbally expressed negative emotion in 17% of the visits. The most commonly used words were: "concern," "scared," "worried," "depressed," and "nervous." Types of emotion expressed were: anxiety (46%), fear (25%), depression (12%), anger (9%), and other (8%). Topics about which emotion was expressed were: symptoms and functional concerns (66%), medical diagnoses and treatments (54%), social issues (14%), and the health care system (9%). Although all patients had terminal cancer, they expressed negative emotion overtly related to death and dying only 2% of the time. CONCLUSIONS: Patients infrequently expressed negative emotion to their oncologists. When they did, they typically expressed anxiety and fear, indicating concern about the future. When patients use emotionally expressive words such as those we described, oncologists should respond empathically, allowing patients to express their distress and concerns more fully. 相似文献
83.
84.
85.
The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. 总被引:6,自引:1,他引:6 下载免费PDF全文
D J Pinsky B Cai X Yang C Rodriguez R R Sciacca P J Cannon 《The Journal of clinical investigation》1995,95(2):677-685
Inducible nitric oxide (NO) produced by macrophages is cytotoxic to invading organisms and has an important role in host defense. Recent studies have demonstrated inducible NO production within the heart, and that cytokine-induced NO mediates alterations in cardiac contractility, but the cytotoxic potential of nitric oxide with respect to the heart has not been defined. To evaluate the role of inducible nitric oxide synthase (iNOS) on cardiac myocyte cytotoxicity, we exposed adult rat cardiac myocytes to either cytokines alone or to activated J774 macrophages in coculture. Increased expression of both iNOS message and protein was seen in J774 macrophages treated with IFN gamma and LPS and cardiac myocytes treated with TNF-alpha, IL-1 beta, and IFN gamma. Increased NO synthesis was confirmed in both the coculture and isolated myocyte preparations by increased nitrite production. Increased NO synthesis was associated with a parallel increase in myocyte death as measured by CPK release into the culture medium as well as by loss of membrane integrity, visualized by trypan blue staining. Addition of the competitive NO synthase inhibitor L-NMMA to the culture medium prevented both the increased nitrite production and the cytotoxicity observed after cytokine treatment in both the isolated myocyte and the coculture experiments. Because transforming growth-factor beta modulates iNOS expression in other cell types, we evaluated its effects on cardiac myocyte iNOS expression and NO-mediated myocyte cytotoxicity. TGF-beta reduced expression of cardiac myocyte iNOS message and protein, reduced nitrite production, and reduced NO-mediated cytotoxicity in parallel. Taken together, these experiments show the cytotoxic potential of endogenous NO production within the heart, and suggest a role for TGF-beta or NO synthase antagonists to mute these lethal effects. These findings may help explain the cardiac response to sepsis or allograft rejection, as well as the progression of dilated cardiomyopathies of diverse etiologies. 相似文献
86.
Poirel L Castanheira M Carrër A Rodriguez CP Jones RN Smayevsky J Nordmann P 《Antimicrobial agents and chemotherapy》2011,55(6):2546-2551
Two bla(OXA-48)-like-positive isolates (Klebsiella pneumoniae and Enterobacter cloacae) were recovered in Argentina in 2008 as part of a large-scale survey focused on multidrug resistance in Enterobacteriaceae. In both cases, sequencing identified β-lactamase OXA-163, differing from OXA-48 by a single amino substitution and a 4-amino-acid deletion. OXA-163 hydrolyzed penicillins, ceftazidime, and cefotaxime, whereas OXA-48 did not. However, OXA-163 had a much lower ability to hydrolyze carbapenems than OXA-48, therefore barely being considered a carbapenemase. In both isolates, the bla(OXA-163) gene was located on plasmids that differed in structure and size. However, a detailed genetic analysis revealed a similar genetic context in those isolates, with the bla(OXA-163) gene being bracketed by novel transposase genes, making this genetic environment different from that reported for the bla(OXA-48) gene. This study identified the first class D β-lactamase compromising both extended-spectrum cephalosporin and carbapenem activities. 相似文献
87.
De Lorenzi F Lohsiriwat V Barbieri B Rodriguez Perez S Garusi C Petit JY Galimberti V Rietjens M 《Breast (Edinburgh, Scotland)》2012,21(3):374-379
Electron intraoperative radiotherapy (ELIOT) has been introduced for breast conservative treatment (BCT) with promising oncological outcome. Thus, immediate breast reconstruction with prosthesis after BCT became possible due to minimal radiation effect on local tissue from ELIOT. We reported oncological and esthetical results of 29 BCT patients who had immediate implant reconstruction plus 21 Gy-ELIOT as the sole radiation treatment. All patients had prosthesis in ipsilateral breast and had simultaneous contralateral augmentation for symmetrical procedure. The average age was 52.3 years. There were stage Ia thirteen cases, stage Ib seven cases, stage IIa six cases and stage IIIb one case and two cases of intraepithelial neoplasia. From 54.2 (36-88) months follow up, the capsular contracture grading in the reconstructed breast from ELIOT-side is comparable with non-irradiated contralateral side. There was one patient who developed local recurrence (LR) and later on dead with breast related event (LR=0.76% per year). There was no primary ipsilateral carcinomas and distant metastasis. 相似文献
88.
M. Mengel B. Sis M. Haas R. B. Colvin P. F. Halloran L. C. Racusen K. Solez L. Cendales A. J. Demetris C. B. Drachenberg C. F. Farver E. R. Rodriguez W. D. Wallace D. Glotz as the Banff meeting report writing committee 《American journal of transplantation》2012,12(3):563-570
The 11th Banff meeting was held in Paris, France, from June 5 to 10, 2011, with a focus on refining diagnostic criteria for antibody‐mediated rejection (ABMR). The major outcome was the acknowledgment of C4d‐negative ABMR in kidney transplants. Diagnostic criteria for ABMR have also been revisited in other types of transplants. It was recognized that ABMR is associated with heterogeneous phenotypes even within the same type of transplant. This highlights the necessity of further refining the respective diagnostic criteria, and is of particular significance for the design of randomized clinical trials. A reliable phenotyping will allow for definition of robust end‐points. To address this unmet need and to allow for an evidence‐based refinement of the Banff classification, Banff Working Groups presented multicenter data regarding the reproducibility of features relevant to the diagnosis of ABMR. However, the consensus was that more data are necessary and further Banff Working Group activities were initiated. A new Banff working group was created to define diagnostic criteria for ABMR in kidneys independent of C4d. Results are expected to be presented at the 12th Banff meeting to be held in 2013 in Brazil. No change to the Banff classification occurred in 2011. 相似文献
89.
90.
Duranton F Cohen G De Smet R Rodriguez M Jankowski J Vanholder R Argiles A;European Uremic Toxin Work Group 《Journal of the American Society of Nephrology : JASN》2012,23(7):1258-1270
An updated review of the existing knowledge regarding uremic toxins facilitates the design of experimental studies. We performed a literature search and found 621 articles about uremic toxicity published after a 2003 review of this topic. Eighty-seven records provided serum or blood measurements of one or more solutes in patients with CKD. These records described 32 previously known uremic toxins and 56 newly reported solutes. The articles most frequently reported concentrations of β2-microglobulin, indoxyl sulfate, homocysteine, uric acid, and parathyroid hormone. We found most solutes (59%) in only one report. Compared with previous results, more recent articles reported higher uremic concentrations of many solutes, including carboxymethyllysine, cystatin C, and parathyroid hormone. However, five solutes had uremic concentrations less than 10% of the originally reported values. Furthermore, the uremic concentrations of four solutes did not exceed their respective normal concentrations, although they had been previously described as uremic retention solutes. In summary, this review extends the classification of uremic retention solutes and their normal and uremic concentrations, and it should aid the design of experiments to study the biologic effects of these solutes in CKD. 相似文献